Global health R&D benefits rich countries too, study argues

As the US reduces its funding for global health research, a new study highlights an important trend: much of this money remains within wealthy countries. The research suggests that investments often lead to inventions that are subsequently repurposed for people in wealthy, donor nations.

During Donald Trump’s second administration, significant changes were made to US global health initiatives. Notably, the US Agency for International Development (USAID) was closed. Additionally, efforts were made to halt overseas sub-awards from the country’s National Institutes of Health (NIH).

These shifts have raised concerns about the future of global health research funding and its impact on low- and middle-income countries.
https://sciencebusiness.net/news/r-d-funding/drug-development/global-health-rd-benefits-rich-countries-too-study-argues

You may also like

Rep Jeffries escalates rhetoric against Noem, says DHS leader should be ‘put on ice permanently’

2026 年 1 月 30 日

Judge Carole Clark expected to make full recovery, remains hospitalized with rehab expected

2026 年 1 月 29 日

WATCH: Utah governor to deliver State of State address

2026 年 1 月 22 日